AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 17940869 — intervention group
Group type: EXPERIMENTAL
Intervention: Asking a doctor for the HBV test
Number of subjects: 442
Study 17940869 — intervention group
Group type: EXPERIMENTAL
Intervention: Need for interpreter services
Number of subjects: 442
Study 15065962 — intervention group
Group type: EXPERIMENTAL
Intervention: Structural Ecosystems Therapy (SET)
Number of subjects: 209
Study 15065962 — intervention group
Group type: COMPARATOR
Intervention: Attention-comparison person-centered condition
Number of subjects: 209
Study 15065962 — intervention group
Group type: COMPARATOR
Intervention: Community control condition
Number of subjects: 209
Study 11265008 — intervention group
Group type: EXPERIMENTAL
Intervention: Femoral neck stress fractures group
Number of subjects: 23
Study 11265008 — intervention group
Group type: COMPARATOR
Intervention: Control group (fifteen patients undergoing iliac crest bone grafting for scaphoid nonunions)
Number of subjects: 23
Study 9539069 — intervention group
Group type: EXPERIMENTAL
Intervention: rhGH (0.3 IU/kg per day)
Number of subjects: 18
Study 9539069 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 8008325 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin, 1 g orally as one dose
Number of subjects: 30
Study 8008325 — intervention group
Group type: COMPARATOR
Intervention: Erythromycin, 500 mg orally four times a day for 7 days
Number of subjects: 30
Study 8008325 — intervention group
Group type: COMPARATOR
Intervention: Erythromycin, 500 mg orally four times a day for 7 days (initial dosage)
Number of subjects: 30
Study 8008325 — intervention group
Group type: COMPARATOR
Intervention: Erythromycin, 250 mg orally four times a day (adjusted dosage)
Number of subjects: 30
Study 2922487 — intervention group
Group type: EXPERIMENTAL
Intervention: Different types of information interventions to promote BSE practice
Number of subjects: 204
Study 2922487 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensory information about the breast
Number of subjects: 204
Study 5015048 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone (20 mg daily for one day before and two days after irradiation)
Number of subjects: 88
Study 5015048 — intervention group
Group type: EXPERIMENTAL
Intervention: Mustine (intravenously)
Number of subjects: 88
Study 5015048 — intervention group
Group type: COMPARATOR
Intervention: No preliminary treatment (Control group)
Number of subjects: 88
Study 732468 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-gut irrigation (wgi)
Number of subjects: 32
Study 732468 — intervention group
Group type: COMPARATOR
Intervention: Elemental diet
Number of subjects: 32
Study 732468 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-gut irrigation with antibiotics (neomycin-bacitracin-clindamycin)
Number of subjects: 32
Study 30824584 — intervention group
Group type: EXPERIMENTAL
Intervention: cobimetinib combined with vemurafenib
Number of subjects: 0
Study 30824584 — intervention group
Group type: COMPARATOR
Intervention: vemurafenib alone
Number of subjects: 0
Study 28093533 — intervention group
Group type: EXPERIMENTAL
Intervention: Deworming intervention with 400 mg of albendazole and educational training about STH infection, treatment, and prevention, conducted twice (May 2013 and November 2013)
Number of subjects: 0
Study 28093533 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 0
Study 25774698 — intervention group
Group type: EXPERIMENTAL
Intervention: Spouse-assisted lifestyle change intervention (nine monthly goal setting telephone calls to participants and support planning calls to spouses over 11 months)
Number of subjects: 255
Study 25774698 — intervention group
Group type: EXPERIMENTAL
Intervention: Spouse-assisted lifestyle change intervention
Number of subjects: 255
Study 25774698 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 255
Study 22640934 — intervention group
Group type: EXPERIMENTAL
Intervention: Manu® soft hand brace
Number of subjects: 10
Study 22640934 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention specified)
Number of subjects: 10
Study 22097198 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardioplegic solution with Salvia miltiorrhizae (SM)
Number of subjects: 30
Study 22097198 — intervention group
Group type: COMPARATOR
Intervention: Cardioplegic solution without Salvia miltiorrhizae (Control)
Number of subjects: 30
Study 19214920 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy (CT) with human premixed insulin b.d. (n=20)
Number of subjects: 61
Study 19214920 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensified therapy (ICT) with Lispro at meals and NPH at bedtime (n=24)
Number of subjects: 61
Study 19214920 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplementary therapy (SIT) with human regular insulin at meals (n=17)
Number of subjects: 61
Study 17264089 — intervention group
Group type: EXPERIMENTAL
Intervention: OSRA-A
Number of subjects: 466
Study 17264089 — intervention group
Group type: EXPERIMENTAL
Intervention: OSRA-D
Number of subjects: 466
Study 17264089 — intervention group
Group type: EXPERIMENTAL
Intervention: DAS28
Number of subjects: 466
Study 17264089 — intervention group
Group type: EXPERIMENTAL
Intervention: OMERACT core set
Number of subjects: 466
Study 15105863 — intervention group
Group type: EXPERIMENTAL
Intervention: New blackcurrant/calcium/gum drink (test product)
Number of subjects: 16
Study 15105863 — intervention group
Group type: EXPERIMENTAL
Intervention: Original blackcurrant/calcium drink
Number of subjects: 16
Study 15105863 — intervention group
Group type: COMPARATOR
Intervention: Conventional blackcurrant drink (positive control)
Number of subjects: 16
Study 15105863 — intervention group
Group type: COMPARATOR
Intervention: Water (negative control)
Number of subjects: 16
Study 12216339 — intervention group
Group type: EXPERIMENTAL
Intervention: Seretide (salmeterol + fluticasone)
Number of subjects: 0
Study 12216339 — intervention group
Group type: EXPERIMENTAL
Intervention: Symbicort (formoterol + budesonide)
Number of subjects: 0
Study 9817170 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-1BB receptor
Number of subjects: 0
Study 9817170 — intervention group
Group type: EXPERIMENTAL
Intervention: LTbeta-R
Number of subjects: 0
Study 9817170 — intervention group
Group type: EXPERIMENTAL
Intervention: Fas
Number of subjects: 0
Study 7654642 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified biophysical profile (computerised cardiotocography, amniotic fluid index, assessment of fetal breathing, tone and gross body movements)
Number of subjects: 145
Study 7654642 — intervention group
Group type: COMPARATOR
Intervention: Standard cardiotocography and maximum pool depth
Number of subjects: 145
Study 7654642 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified biophysical profile
Number of subjects: 145
Study 7654642 — intervention group
Group type: EXPERIMENTAL
Intervention: Amniotic fluid index
Number of subjects: 145
Study 7654642 — intervention group
Group type: COMPARATOR
Intervention: Maximum pool depth
Number of subjects: 145
Study 2780057 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoprofen (100 mg in 5 ml saline)
Number of subjects: 18
Study 2780057 — intervention group
Group type: COMPARATOR
Intervention: Saline (5 ml)
Number of subjects: 18
Study 1107090 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% hydrocortisone in a stabilized 10% urea cream
Number of subjects: 49
Study 1107090 — intervention group
Group type: COMPARATOR
Intervention: 0.1% betamethasone 17-valerate cream
Number of subjects: 49
Study 31831384 — intervention group
Group type: EXPERIMENTAL
Intervention: Foods and beverages consumed at ECE centers
Number of subjects: 840
Study 31831384 — intervention group
Group type: COMPARATOR
Intervention: Foods and beverages consumed elsewhere
Number of subjects: 840
Study 31831384 — intervention group
Group type: EXPERIMENTAL
Intervention: Foods and beverages consumed on weekdays
Number of subjects: 840
Study 31831384 — intervention group
Group type: COMPARATOR
Intervention: Foods and beverages consumed on weekends
Number of subjects: 840
Study 31689320 — intervention group
Group type: EXPERIMENTAL
Intervention: Adhere4U mobile medication manager application
Number of subjects: 138
Study 31689320 — intervention group
Group type: COMPARATOR
Intervention: Conventional care (control group)
Number of subjects: 138
Study 31689320 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported adherence using BAASIS
Number of subjects: 138
Study 31689320 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported adherence using VAS
Number of subjects: 138
Study 28362208 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad5-EBOV high-dose group
Number of subjects: 0
Study 28362208 — intervention group
Group type: COMPARATOR
Intervention: Ad5-EBOV other dose groups
Number of subjects: 0
Study 28362208 — intervention group
Group type: EXPERIMENTAL
Intervention: Males
Number of subjects: 0
Study 28362208 — intervention group
Group type: COMPARATOR
Intervention: Females
Number of subjects: 0
Study 28362208 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing age groups
Number of subjects: 0
Study 28362208 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing body mass index (BMI)
Number of subjects: 0
Study 26573447 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical chamomile oil, applied twice daily for 4 weeks
Number of subjects: 26
Study 26573447 — intervention group
Group type: COMPARATOR
Intervention: Placebo, applied twice daily for 4 weeks
Number of subjects: 26
Study 22958202 — intervention group
Group type: EXPERIMENTAL
Intervention: AZD6370 10-650 mg
Number of subjects: 0
Study 22958202 — intervention group
Group type: COMPARATOR
Intervention: AZD6370 50 and 80 mg
Number of subjects: 0
Study 22958202 — intervention group
Group type: EXPERIMENTAL
Intervention: AZD6370 10-20 mg with food
Number of subjects: 0
Study 22958202 — intervention group
Group type: COMPARATOR
Intervention: Short-acting insulin 4 U
Number of subjects: 0
Study 22064369 — intervention group
Group type: EXPERIMENTAL
Intervention: MgSO(4) supplementation
Number of subjects: 60
Study 22064369 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 60
Study 19896019 — intervention group
Group type: EXPERIMENTAL
Intervention: Partner-led recruitment approach
Number of subjects: 555
Study 19896019 — intervention group
Group type: COMPARATOR
Intervention: Other recruitment strategies (clinicians, public events, local organizations, special events)
Number of subjects: 555
Study 16827763 — intervention group
Group type: EXPERIMENTAL
Intervention: Levonorgestrel intrauterine system (LNG-IUS)
Number of subjects: 79
Study 16827763 — intervention group
Group type: COMPARATOR
Intervention: Thermal balloon ablation
Number of subjects: 79
Study 14735861 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrarectal lidocaine, 20 mg (group 1)
Number of subjects: 140
Study 14735861 — intervention group
Group type: COMPARATOR
Intervention: Placebo (group 2)
Number of subjects: 140
Study 11274244 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 17
Study 11274244 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 17
Study 9877141 — intervention group
Group type: EXPERIMENTAL
Intervention: V1 skate (V1)
Number of subjects: 10
Study 9877141 — intervention group
Group type: EXPERIMENTAL
Intervention: V2‐alternate (V2A)
Number of subjects: 10
Study 9877141 — intervention group
Group type: EXPERIMENTAL
Intervention: V2 skate (V2)
Number of subjects: 10
Study 9877141 — intervention group
Group type: EXPERIMENTAL
Intervention: V1, V2, V2A
Number of subjects: 10
Study 8033498 — intervention group
Group type: EXPERIMENTAL
Intervention: Orlistat (30 to 1200 mg, three times a day for 9 to 10 days)
Number of subjects: 171
Study 8033498 — intervention group
Group type: COMPARATOR
Intervention: Placebo (matching placebo, three times a day for 9 to 10 days)
Number of subjects: 171
Study 2644922 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative radiation therapy (IORT)
Number of subjects: 119
Study 2644922 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 119
Study 980651 — intervention group
Group type: EXPERIMENTAL
Intervention: Recall after 1 week
Number of subjects: 76
Study 980651 — intervention group
Group type: EXPERIMENTAL
Intervention: Recall after 6 weeks
Number of subjects: 76
Study 980651 — intervention group
Group type: COMPARATOR
Intervention: Retest after 1 week
Number of subjects: 76
Study 980651 — intervention group
Group type: COMPARATOR
Intervention: Retest after 6 weeks
Number of subjects: 76
Study 30353208 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A (hip fixed at 50° and knee flexed at 90° for 6 hours post-operatively)
Number of subjects: 135
Study 30353208 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B (hip elevated at 30° and knee flexed at 45° for 6 hours post-operatively)
Number of subjects: 135
Study 30353208 — intervention group
Group type: COMPARATOR
Intervention: Group C (affected knee fully extended after surgery)
Number of subjects: 135
Study 30179110 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel (12 weekly doses) followed by 12 weeks of treatment with four cycles of anthracycline
Number of subjects: 242
Study 30179110 — intervention group
Group type: EXPERIMENTAL
Intervention: Model combining tumor subtype and midtreatment ΔADC
Number of subjects: 242
Study 27864165 — intervention group
Group type: EXPERIMENTAL
Intervention: Text to Move (TTM) intervention group
Number of subjects: 126
Study 27864165 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 126
Study 24815121 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive education program based on the Theory of Planned Behavior (TPB)
Number of subjects: 123
Study 24815121 — intervention group
Group type: COMPARATOR
Intervention: Brochure only (Control)
Number of subjects: 123
Study 22799492 — intervention group
Group type: EXPERIMENTAL
Intervention: Read to Me! literacy package
Number of subjects: 1051
Study 22799492 — intervention group
Group type: COMPARATOR
Intervention: Control (no literacy package)
Number of subjects: 1051
Study 21050287 — intervention group
Group type: EXPERIMENTAL
Intervention: Lp-PLA₂ activity
Number of subjects: 19037
Study 21050287 — intervention group
Group type: EXPERIMENTAL
Intervention: Lp-PLA₂ mass
Number of subjects: 19037
Study 21050287 — intervention group
Group type: EXPERIMENTAL
Intervention: Apolipoprotein-B100
Number of subjects: 19037
Study 21050287 — intervention group
Group type: COMPARATOR
Intervention: Simvastatin
Number of subjects: 19037
Study 18156658 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate supplementation (0.25 g.kg(‐1).h(‐1)) during hours 0-12 and 24-36 postexercise
Number of subjects: 8
Study 18156658 — intervention group
Group type: COMPARATOR
Intervention: Placebo (equal volume) during hours 0-12 and 24-36 postexercise
Number of subjects: 8
Study 15955653 — intervention group
Group type: EXPERIMENTAL
Intervention: 80w/v% trichloroacetic acid (TCA)
Number of subjects: 169
Study 15955653 — intervention group
Group type: COMPARATOR
Intervention: NonTCA treatment
Number of subjects: 169
Study 12196838 — intervention group
Group type: EXPERIMENTAL
Intervention: Ganciclovir (GCV) + Intravenous Immunoglobulin (IVIG)
Number of subjects: 25
Study 12196838 — intervention group
Group type: COMPARATOR
Intervention: Control group (prednisone, glucurone, Luminal, Xiaoyanlidanpian)
Number of subjects: 25
Study 9934915 — intervention group
Group type: EXPERIMENTAL
Intervention: Instillation of intratracheal surfactant (80 mL/m2)
Number of subjects: 42
Study 9934915 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 42
Study 8689457 — intervention group
Group type: EXPERIMENTAL
Intervention: hylan G-F 20 with NSAID continuation
Number of subjects: 102
Study 8689457 — intervention group
Group type: EXPERIMENTAL
Intervention: hylan G-F 20 alone (NSAID discontinuation)
Number of subjects: 102
Study 8689457 — intervention group
Group type: COMPARATOR
Intervention: NSAIDs alone
Number of subjects: 102
Study 2178582 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (500 mg)
Number of subjects: 202
Study 2178582 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfamethoxazole and trimethoprim (160 mg/800 mg)
Number of subjects: 202
Study 2178582 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 202
Study 375377 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine (0.6 mg.kg‐1h‐1)
Number of subjects: 4
Study 30863045 — intervention group
Group type: EXPERIMENTAL
Intervention: tiotropium + olodaterol
Number of subjects: 15000
Study 28633627 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational intervention (400 patients), delivered by a nurse trained by an expert psychologist, in 32 sessions (1 to 12 fortnightly, 13 to 32 monthly) on top of standard diet and exercise
Number of subjects: 864
Study 28633627 — intervention group
Group type: COMPARATOR
Intervention: Control group (446 patients), received usual follow-up
Number of subjects: 864
Study 28633627 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational intervention
Number of subjects: 864
Study 26712979 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TA) 20 mg/kg diluted to 25 cc with normal saline (Group T)
Number of subjects: 80
Study 26712979 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (Group C)
Number of subjects: 80
Study 25044176 — intervention group
Group type: EXPERIMENTAL
Intervention: Colecalciferol (280 μg daily for 2 weeks, then 140 μg daily for 10 weeks)
Number of subjects: 16
Study 25044176 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 22469604 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclamen europaeum nasal spray (CE) once daily for 15 days
Number of subjects: 99
Study 22469604 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclamen europaeum nasal spray (CE)
Number of subjects: 99
Study 22469604 — intervention group
Group type: COMPARATOR
Intervention: Placebo nasal spray
Number of subjects: 99
Study 19578802 — intervention group
Group type: EXPERIMENTAL
Intervention: ethinyl estradiol + cyproterone acetate
Number of subjects: 25
Study 19578802 — intervention group
Group type: EXPERIMENTAL
Intervention: ethinyl estradiol + drospirenone
Number of subjects: 25
Study 19578802 — intervention group
Group type: EXPERIMENTAL
Intervention: ethinyl estradiol + gestodene
Number of subjects: 25
Study 19578802 — intervention group
Group type: COMPARATOR
Intervention: Control group (not taking OC)
Number of subjects: 25
Study 18075447 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg of prednisone for 5 days preoperatively and 9 days postoperatively
Number of subjects: 26
Study 18075447 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 5 days preoperatively and 9 days postoperatively
Number of subjects: 26
Study 18075447 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone
Number of subjects: 26
Study 18075447 — intervention group
Group type: EXPERIMENTAL
Intervention: POSE scoring system
Number of subjects: 26
Study 15191588 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided Tissue Regeneration (GTR) surgery
Number of subjects: 27
Study 15191588 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional Flap (CF) surgery
Number of subjects: 27
Study 15191588 — intervention group
Group type: COMPARATOR
Intervention: Control sites (unaffected healthy sites)
Number of subjects: 27
Study 12361815 — intervention group
Group type: EXPERIMENTAL
Intervention: Caspofungin (50 mg) intravenously once daily for 7 to 21 days
Number of subjects: 177
Study 12361815 — intervention group
Group type: COMPARATOR
Intervention: Fluconazole (200 mg) intravenously once daily for 7 to 21 days
Number of subjects: 177
Study 12361815 — intervention group
Group type: EXPERIMENTAL
Intervention: Caspofungin
Number of subjects: 177
Study 12361815 — intervention group
Group type: COMPARATOR
Intervention: Fluconazole
Number of subjects: 177
Study 9441569 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer‐generated reminders
Number of subjects: 1009
Study 9441569 — intervention group
Group type: COMPARATOR
Intervention: No reminders
Number of subjects: 1009
Study 9441569 — intervention group
Group type: EXPERIMENTAL
Intervention: Both types of reminders
Number of subjects: 1009
Study 10030329 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulphadoxine-pyrimethamine
Number of subjects: 1264
Study 10030329 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1264
Study 2000036 — intervention group
Group type: EXPERIMENTAL
Intervention: Max EPA (fish oil concentrate)
Number of subjects: 27
Study 2000036 — intervention group
Group type: COMPARATOR
Intervention: Olive oil
Number of subjects: 27
Study 2000036 — intervention group
Group type: COMPARATOR
Intervention: Olive oil with added cholesterol (same amount as in Max EPA)
Number of subjects: 27
Study 6666227 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg ISDN sustained-release, three times a day
Number of subjects: 40
Study 6666227 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg ISDN sustained-release, three times a day
Number of subjects: 40
Study 6666227 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mg ISDN sustained-release, three times a day
Number of subjects: 40
Study 6666227 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 28463015 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia (CBT-I), delivered in a six-session group program
Number of subjects: 81
Study 28463015 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 81
Study 28463015 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia (CBT-I)
Number of subjects: 81
Study 29273847 — intervention group
Group type: EXPERIMENTAL
Intervention: Apically positioned flap (APF)
Number of subjects: 0
Study 29273847 — intervention group
Group type: EXPERIMENTAL
Intervention: APF plus xenogeneic collagen matrix (XCM)
Number of subjects: 0
Study 29273847 — intervention group
Group type: EXPERIMENTAL
Intervention: APF plus free gingival graft (FGG)
Number of subjects: 0
Study 29273847 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 29273847 — intervention group
Group type: EXPERIMENTAL
Intervention: APF
Number of subjects: 0
Study 29273847 — intervention group
Group type: EXPERIMENTAL
Intervention: XCM
Number of subjects: 0
Study 29273847 — intervention group
Group type: EXPERIMENTAL
Intervention: FGG
Number of subjects: 0
Study 27145292 — intervention group
Group type: EXPERIMENTAL
Intervention: tACSbm (20 Hz and < 400 μA for 30-min)
Number of subjects: 60
Study 27145292 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual rehabilitation program without tACSbm)
Number of subjects: 60
Study 27145292 — intervention group
Group type: EXPERIMENTAL
Intervention: tACSbm
Number of subjects: 60